文献速递中毒与环境急症重症综合管理与镇静镇痛

全激动剂治疗严重 precipitated 阿片戒断:病例系列与回顾性分析

Utilization of full-agonist therapy for severe precipitated opioid withdrawal: A case series and retrospective analysis.
PubMed 文献 · Am J Emerg Med · 2025-04-28
一句话结论对疑似 precipitated 阿片戒断的严重患者,使用氢吗啡酮后多数戒断症状改善,并均成功过渡到丁丙诺啡处方。

该单中心回顾性病例系列纳入2023年5月1日至2024年5月31日由医学毒理服务接诊、因 precipitated 阿片戒断接受氢吗啡酮治疗的13例患者,所有患者均疑似 precipitated 戒断(最常见由丁丙诺啡引起)。几乎所有患者给药后戒断症状改善,仅1例改善不充分需气管插管和镇静。全部患者出院时均持有丁丙诺啡处方。作者认为该方法可行,但需进一步研究其安全性和有效性。

要点

  • 13例疑似 precipitated 阿片戒断(最常见由丁丙诺啡引起)患者接受氢吗啡酮后,几乎所有患者戒断症状改善。
  • 仅1例对氢吗啡酮反应不充分,需气管插管和镇静。
  • 全部13例患者出院时均持有丁丙诺啡处方,实现后续丁丙诺啡诱导。
  • 作者认为用氢吗啡酮治疗 precipitated 戒断可行,但需进一步研究其安全性和有效性。

适用人群与场景

  • 2023年5月1日至2024年5月31日在一家医院由医学毒理服务接诊、因 precipitated 阿片戒断接受氢吗啡酮治疗的患者。
  • 共13例,所有患者均疑似 precipitated 阿片戒断,最常见由丁丙诺啡引起。

处置流程与药物剂量

  • 对疑似 precipitated 阿片戒断的严重患者使用氢吗啡酮(短效全阿片激动剂)治疗,随后进行丁丙诺啡诱导;原文未写明氢吗啡酮剂量、途径和频次。
  • 全部患者出院时均持有丁丙诺啡处方。

红旗征与不能漏的情况

  • 1例患者对氢吗啡酮改善不充分,需要气管插管和镇静。

研究设计与关键结果

  • 研究类型为单中心回顾性病历回顾和病例系列,共纳入13例疑似 precipitated 阿片戒断患者。
  • 几乎所有患者接受氢吗啡酮后戒断症状改善;仅1例改善不充分,需气管插管和镇静。
  • 全部患者出院时均持有丁丙诺啡处方。

证据类型、等级与局限

  • 证据类型:单中心回顾性病历回顾和病例系列。
  • 作者结论:用氢吗啡酮治疗 precipitated 阿片戒断可行,在本研究人群中允许后续丁丙诺啡诱导;需进一步研究确定该方法相对于传统方法的安全性和有效性。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对疑似 precipitated 阿片戒断的严重患者,使用氢吗啡酮治疗可行,并可在本研究中实现后续丁丙诺啡诱导。
  • 作者指出,需进一步研究确定该方法相对于传统方法的安全性和有效性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: We aim to describe our experience in treating severe precipitated opioid withdrawal with hydromorphone - a short-acting, full opioid agonist - followed by buprenorphine induction.

METHODS: This is a retrospective chart review and case series conducted at a single hospital from May 1, 2023 to May 31, 2024 of patients who were seen by a medical toxicology service and received hydromorphone to treat precipitated opioid withdrawal. Descriptive statistics were used to analyze the results as appropriate.

RESULTS: There were 13 patients identified over the study period with severe opioid withdrawal, all suspected to be in precipitated withdrawal (most commonly by buprenorphine). Nearly all patients included in this study had improved withdrawal symptoms after administration of hydromorphone. There was only one patient that did not have adequate improvement with hydromorphone, and this individual required endotracheal intubation and sedation. All patients were discharged with a buprenorphine prescription.

CONCLUSIONS: The use of hydromorphone to treat precipitated opioid withdrawal symptoms is feasible and, in our study population, allowed for subsequent buprenorphine induction. Further study is needed to determine safety and efficacy of this approach versus traditional methods.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Chakraborty A, Strand A, Gooley B, et al. Utilization of full-agonist therapy for severe precipitated opioid withdrawal: A case series and retrospective analysis. Am J Emerg Med. 2025. PMID: 40344869. doi:10.1016/j.ajem.2025.04.052

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。